Proteomics-based identification of differentially expressed genes in human gliomas: Down-regulation of SIRT2 gene

Biochemical and Biophysical Research Communications

Volumn 309, Issue 3, 2003, Pages 558-566

  Hiratsuka, Masaharu ^a   Inoue, Toshiaki ^a   Toda, Tosifusa ^b   Kimura, Narimichi ^b   Shirayoshi, Yasuaki ^a   Kamitani, Hideki ^c   Watanabe, Takashi ^c   Ohama, Eisaku ^c   Tahimic, Candice G T ^a   Kurimasa, Akihiro ^a   Oshimura, Mitsuo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

19q13; Cytoskeleton; Glioma; Growth inhibition; Proteomics; SIRT2

Indexed keywords

CYTOSKELETON PROTEIN; ENZYME; MOLECULAR MARKER; RNA; SIRTUIN HOMOLOGUE 2 PROTEIN; TUBULIN DEACETYLASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GLIOMA; HUMAN; HUMAN TISSUE; MICROTUBULE; MOLECULAR CLONING; MOLECULAR GENETICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

EID: 0041829415     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.029     Document Type: Article

References (26)

1. Fueyo J., Gomez-Manzano C., Yung W.K., Kyritsis A.P. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies. Neurology. 51:1998;1250-1255.
2. Rasheed B.K., Wiltshire R.N., Bigner S.H., Bigner D.D. Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol. 11:1999;162-167.
3. von Deimling A., Nagel J., Bender B., Lenartz D., Schramm J., Louis D.N., Wiestler O.D. Deletion mapping of chromosome 19 in human gliomas. Int. J. Cancer. 57:1994;676-680.
4. Vandeputte D.A., Meije C.B., van Dartel M., Leenstra S., IJlst-Keizers H., Das P.K., Troost D., Bosch D.A., Baas F., Hulsebos T.J. GOA, a novel gene encoding a ring finger B-box coiled-coil protein, is overexpressed in astrocytoma. Biochem. Biophys. Res. Commun. 286:2001;574-579.
5. Michiels E.M., Oussoren E., Van Groenigen M., Pauws E., Bossuyt P.M., Voute P.A., Baas F. Genes differentially expressed in medulloblastoma and fetal brain. Physiol. Genomics. 1:1999;83-91.
6. Nishigaki R., Shinohara T., Toda T., Omori A., Ichinose S., Itoh M., Shirayoshi Y., Kurimasa A., Oshimura M. An extra human chromosome 21 reduces mlc-2a expression in chimeric mice and Down syndrome. Biochem. Biophys. Res. Commun. 295:2002;112-118.
7. Toda T., Kaji K., Kimura N. TMIG-2DPAGE: a new concept of two-dimensional gel protein database for research on aging. Electrophoresis. 19:1998;344-348.
8. Kleuhues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumors. Brain Pathol. 3:1993;255-268.
9. Formstecher E., Ramos J.W., Fauquet M., Calderwood D.A., Hsieh J.C., Canton B., Nguyen X.T., Barnier J.V., Camonis J., Ginsberg M.H., Chneiweiss H. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell. 1:2001;239-250.
10. Hao C., Beguinot F., Condorelli G., Trencia A., Van Meir E.G., Yong V.W., Parney I.F., Roa W.H., Petruk K.C. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res. 61:2001;1162-1170.
11. Asamoto M., Cohen S.M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. Cancer Lett. 83:1994;201-207.
12. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell. 11:2003;437-444.
13. Bigner S.H., Vogelstein B. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol. 1:1990;12-18.
14. Cleveland D.W., Mao Y., Sullivan K.F. Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell. 112:2003;407-421.
15. Gu Y., Ihara Y. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J. Biol. Chem. 275:2000;17917-17920.
16. dos Remedios C.G., Chhabra D., Kekic M., Dedova I.V., Tsubakihara M., Berry D.A., Nosworthy N.J. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol. Rev. 83:2003;433-473.
17. Mornet D., Bonet-Kerrache A. Neurocalcin-actin interaction. Biochim. Biophys. Acta. 1549:2001;197-203.
18. Binder D.K., Berger M.S. Proteases and the biology of glioma invasion. J. Neurooncol. 56:2002;149-158.
19. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., Tainsky M.A. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23:2003;3173-3185.
20. Reis R.M., Nakamura M., Masuoka J., Watanabe T., Colella S., Yonekawa Y., Kleihues P., Ohgaki H. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathol. 101:2001;297-304.
21. Jaffrey R.G., Pritchard S.C., Clark C., Murray G.I., Cassidy J., Kerr K.M., Nicolson M.C., McLeod H.L. Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer. Cancer Res. 60:2000;4349-4352.
22. Rickman D.S., Bobek M.P., Misek D.E., Kuick R., Blaivas M., Kurnit D.M., Taylor J., Hanash S.M. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61:2001;6885-6891.
23. Steece-Collier K., Maries E., Kordower J.H. Etiology of Parkinson's disease: genetics and environment revisited. Proc. Natl. Acad. Sci. USA. 99:2002;13972-13974.
24. Gordin A., Kaakkola S., Teravainen H. Position of COMT inhibition in the treatment of Parkinson's disease. Adv. Neurol. 91:2003;237-250.
25. Bouterfa H., Picht T., Kess D., Herbold C., Noll E., Black P.M., Roosen K., Tonn J.C. Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. Neurosurgery. 46:2000;419-430.
26. Vedoy C.G., Sogayar M.C. Isolation and characterization of genes associated with the anti-tumor activity of glucocorticoids. Brain Res. Mol. Brain Res. 106:2002;57-69.